THOMPSON SIEGEL & WALMSLEY LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1008322 RICHMOND, VA

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$13,422,946

-$2,185,092 QoQ

Shares Held

176,967

-24.5% QoQ

Ownership

0.272%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 85.30064927359338.ToString("F0")% Shared 0.ToString("F0")% None 14.699350726406617.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

THOMPSON SIEGEL & WALMSLEY LLC holds $124,816,124 across 6 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	3,838,892	$51,863,430
2	PRGO	PERRIGO Co plc	3,753,900	$40,316,886
3	LNTH	Lantheus Holdings, Inc. This page	176,967	$13,422,946
4	ETON	Eton Pharmaceuticals, Inc.	406,089	$10,022,276
5	ANIP	Ani Pharmaceuticals Inc	113,003	$8,689,930
6	XERS	Xeris Biopharma Holdings, Inc.	86,320	$500,656

All Filings in LNTH

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,422,946	176,967	-24.5%	Shares	Defined	2026-05-11
2025-12-31	$15,608,038	234,531	-14.5%	Shares	Defined	2026-02-10
2025-09-30	$14,063,410	274,194	+86.5%	Shares	Defined	2025-11-12
2025-06-30	$12,033,256	146,998	+7.3%	Shares	Defined	2025-08-06
2025-03-31	$13,373,347	137,022	-13.3%	Shares	Defined	2025-05-09
2024-12-31	$14,131,459	157,964	+107.1%	Shares	Defined	2025-02-10
2024-09-30	$8,372,169	76,284	—	Shares	Defined	2024-11-12
No filing history on record for this holder in this stock.